Effect of insulinlike growth factor-1 treatment in children with cystic fibrosis

Journal of Pediatric Gastroenterology and Nutrition

Volumn 33, Issue 5, 2001, Pages 576-581

  Bucuvalas, John C ^a,b,c   Chernausek, Steven D ^a   Alfaro, Mary Pat ^a   Krug, Susan K ^a   Ritschel, Wolfgang ^a   Wilmott, Robert W ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CYSTIC FIBROSIS FOUNDATION   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Cystic fibrosis; Insulinlike growth factor 1; Malnutrition

Indexed keywords

GLUCOSE; INSULIN; SOMATOMEDIN C;

ADOLESCENT; ADVERSE DRUG REACTION; ARTICLE; BODY COMPOSITION; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYSTIC FIBROSIS; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG HALF LIFE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FORCED EXPIRATORY VOLUME; GLUCOSE BLOOD LEVEL; GROWTH RATE; HUMAN; HUMAN TISSUE; INSULIN BLOOD LEVEL; INSULIN LIKE ACTIVITY; INSULIN SENSITIVITY; LEAN BODY WEIGHT; MALE; MALNUTRITION; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; WEIGHT GAIN;

ADOLESCENT; BLOOD GLUCOSE; BODY COMPOSITION; BODY HEIGHT; CHILD; CROSS-OVER STUDIES; CYSTIC FIBROSIS; DENSITOMETRY, X-RAY; DOUBLE-BLIND METHOD; FEMALE; GROWTH; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INTESTINAL ABSORPTION; MALE; NUTRITION DISORDERS; RESPIRATORY FUNCTION TESTS;

TRIXIS;

EID: 0035215468     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-200111000-00012     Document Type: Article

References (41)

1. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto
2. Nutritional assessment and management in cystic fibrosis: A consensus report
3. Nitrogen deposition in malnourished children with cystic fibrosis
4. Nutritional rehabilitation in cystic fibrosis: A 5 year follow-up study
5. Improved growth and clinical, nutritional, and respiratory changes in response to nutritional therapy in cystic fibrosis
6. Nutritional rehabilitation in cystic fibrosis: Controlled studies of effects on nutritional growth retardation, body protein turnover, and course of pulmonary disease
7. Oxygen-assisted exercise training in adult cystic fibrosis patients with pulmonary limitation to exercise
8. Long-term effects of exercise training and hyperalimentation in adult cystic fibrosis patients with severe pulmonary dysfunction
9. Relationships among nutritional status and skeletal and respiratory muscle function in cystic fibrosis: Does early dietary supplementation make a difference?
10. Outcome measures for clinical trials in cystic fibrosis. Summary of a Cystic Fibrosis Foundation consensus conference
11. Diminished concentrations of insulin-like growth factor I in cystic fibrosis
12. Anabolic effects of growth hormone treatment in young children with cystic fibrosis
13. Anabolic effect of biosynthetic growth hormone in cystic fibrosis patients
14. Effects of growth hormone treatment in children with cystic fibrosis: The National Cooperative Growth Study experience
15. Effect of hypersomatostatinemia on growth hormone secretion in cystic fibrosis patients with diabetes
16. Normal spontaneous and stimulated GH levels despite decreased IGF-I concentrations in cystic fibrosis patients
17. Role of insulin-like growth factor-1 in reversing catabolism
18. Role of insulin-like growth factors and growth hormone in reversing catabolic states
19. Effects of recombinant insulin-like growth factor-I (IGF-I) and growth hormone on serum IGF-binding proteins in calorically restricted adults
20. Percentiles for body mass index in U.S. children 5 to 17 years of age
21. The diagnosis of cystic fibrosis: A consensus statement. Cystic Fibrosis Foundation Consensus Panel
22. Long-term treatment of growth hormone insensitivity syndrome with IGF-I. Results of the European Multicentre Study
23. IGF-I treatment of adult patients with Laron syndrome: Preliminary results
24. Resistance to the growth-promoting and metabolic effects of growth hormone in children with chronic liver disease
25. Growth hormone insensitivity associated with elevated circulating growth hormonebinding protein in children with Alagille syndrome and short stature
26. Relation between insulin-like growth factor-1, body mass index, and clinical status in cystic fibrosis
27. Serum leptin and IGF-I levels in cystic fibrosis
28. Effects of recombinant human insulin-like growth factor-I (rhIGF-I) on total and free IGF-I concentrations, IGF-binding proteins, and glycemic response in humans
29. Pharmacokinetics of recombinant human insulin-like growth factor I given subcutaneously to healthy volunteers and to patients with growth hormone receptor deficiency
30. Pharmacokinetics of insulin-like growth factor I in hypopituitarism: Correlation with binding proteins
31. Recombinant human growth hormone for reconditioning of respiratory muscle after lung volume reduction surgery
32. Short-term treatment with different doses of human growth hormone in adult patients with growth hormone deficiency
33. Effects of insulin-like growth factor-I on glucose tolerance, insulin levels, and insulin secretion
34. Insulin-like growth factor-I improves glucose and lipid metabolism in type 2 diabetes mellitus
35. Glucose tolerance in patients with cystic fibrosis: Five year prospective study
36. Insulin resistance is associated with decreased clinical status in cystic fibrosis
37. Insulin resistance with altered secretory kinetics and reduced proinsulin in cystic fibrosis patients
38. Reduced pancreatic insulin release and reduced peripheral insulin sensitivity contribute to hyperglycaemia in cystic fibrosis
39. Proteolysis associated with insulin resistance in cystic fibrosis
40. Hepatic insulin resistance and defects in substrate utilization in cystic fibrosis